EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY-NC 3.0

Nasal Cytology as a Complementary Cellular Window in Severe Asthma Phenotyping: Comments on the BRISA Study [Letter]

Matteo Gelardi iD

Journal of Asthma and Allergy · 2026-06 · Volume 19 · 1-3

DOI: 10.2147/jaa.s635145 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Journal of Asthma and Allergy, 2026-06. Verfasst von Matteo Gelardi. Beteiligte Einrichtung: Unit of Otolaryngology, Department of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A Multi-Compartment Cytological Approach to Severe Asthma Phenotyping: The BRISA Study", recently published in the Journal of Asthma and Allergy. 1 The authors should be congratulated for addressing a clinically relevant and still unresolved issue, namely the need for more accurate inflammatory phenotyping in severe asthma through the integration of nasal cytology, induced sputum, peripheral blood, and circulating biomarkers.The BRISA study is particularly valuable because it moves beyond the concept of a single biomarker and proposes a multicompartment model of airway inflammation.1 This approach is consistent with the current understanding of severe asthma as a heterogeneous disease, in which systemic biomarkers, lower airway inflammation, and upper airway involvement may not always overlap.2,3 The finding that nasal cytology alone cannot replace induced sputum for inflammatory phenotyping is therefore important and clinically sound.However, we believe that this conclusion should not reduce the perceived value of nasal cytology, but rather help define its most appropriate role within a precision medicine framework.Nasal cytology should be interpreted not as a surrogate of induced sputum, but as a complementary cellular window on the upper airways.Its main strength lies in the direct observation of the nasal mucosa, allowing the identification of inflammatory cells, including eosinophils, mast cells, neutrophils, lymphocytes, and epithelial alterations.4 In this sense, nasal cytology does not merely provide a numerical count of inflammatory cells, but also offers morphological information regarding epithelial integrity, cellular activation, cytological phenotypes, mucus production, and possible mixed inflammatory patterns.This distinction is clinically relevant.Severe asthma is frequently associated with allergic rhinitis, chronic rhinosinusitis, chronic rhinosinusitis with nasal polyps, and non-steroidal anti-inflammatory drug-exacerbated respiratory disease.1,5 In the BRISA cohort, 72% of patients had allergic rhinitis, 50% had chronic rhinosinusitis with nasal polyps, and 27.3% had nonsteroidal anti-inflammatory drug-exacerbated respiratory disease (N-ERD). 1 These comorbidities may contribute to disease burden, poor control, exacerbations, and therapeutic complexity.In patients with severe asthma, the nasal compartment may therefore represent not only an anatomical extension of lower airway disease, but also an independent inflammatory district with its own cellular features.The incomplete agreement between nasal cytology and induced sputum observed in the BRISA study may thus reflect true biological heterogeneity between upper and lower airway compartments, rather than a limitation of nasal cytology itself. 1 Indeed, the authors reported poor concordance between induced sputum and nasal cytology inflammatory patterns, with a kappa index of -0.0862.They also observed that nasal cytology predominantly showed neutrophilic or mixed inflammatory patterns, whereas eosinophilic inflammation was more frequent in induced sputum. 1 From this perspective, the lack of full concordance between nasal and bronchial cytology should be considered informative.A patient with eosinophilic sputum and non-eosinophilic nasal cytology, or conversely a patient with marked nasal eosinophilia, mast-cell inflammation, or mixed eosinophilic-mast-cell inflammation and non-eosinophilic sputum, may

Autor:innen und Institutionen

  • Unit of Otolaryngology, Department of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy.

ORCID-Profile: Matteo Gelardi

Zitieren

APA

Gelardi, M. (2026). Nasal Cytology as a Complementary Cellular Window in Severe Asthma Phenotyping: Comments on the BRISA Study [Letter]. Journal of Asthma and Allergy, Volume 19, 1-3. https://doi.org/10.2147/jaa.s635145

Vancouver

Gelardi M. Nasal Cytology as a Complementary Cellular Window in Severe Asthma Phenotyping: Comments on the BRISA Study [Letter]. Journal of Asthma and Allergy. 2026;Volume 19:1-3. doi:10.2147/jaa.s635145

BibTeX
@article{Gelardi2026,
  author = {Gelardi, Matteo},
  title = {Nasal Cytology as a Complementary Cellular Window in Severe Asthma Phenotyping: Comments on the BRISA Study [Letter]},
  journal = {Journal of Asthma and Allergy},
  year = {2026},
  volume = {Volume 19},
  pages = {1--3},
  doi = {10.2147/jaa.s635145}
}
Kostenlos starten →